ARCHIVES

Drug Discover Groups Recompetition Approved, But Advisors Scale Back Model Development

This article is from The Cancer Letter archive.

Vol. 17 No. 11 | March 15, 1991

Download PDF Visit The Full Archive

Related Articles

Tissue of Origin Test Consistent With Diagnosis In Blinded Validation Study

January 28, 2011

Organ Site Grants Fare Badly In NIH Study Section Review; RPMI, UT Galveston, Rush Compete For HQ

October 21, 1983

NIH Clinical Center Offers Sabbatical In Clinical Research Management

October 1, 2010

Starr Foundation Gives $100 Million To Form Cancer Consortium.

September 29, 2006

Final Issue Of Decade; Office Closed, But Not Phone Or Fax

December 15, 1989

Breast Cancer Researchers Plan Collaborative Studies

February 27, 2004